CEoT 2021

Save The Date!

"Immunosuppression minimization: How Biomarkers Can Play a Role"

Attend our symposium on Friday, February 26 (4:30-5:45 PM, EST)  featuring a live Q&A  and discover from our experts how biomarkers are the key to optimizing minimization strategies.

Key Take-Aways

  • Connect with clinicians and experts
  • Identify how to utilize biomarkers in the care of challenging transplant patients
  • Uncover new data from REVERSE and PRESERVE for biomarker utilization in liver transplant patients
  • Review real life experience in biomarker use and immunosuppression minimization

Submit your question ahead and automatically receive a recording of our educational  Symposium if you can't make it!

 
josh L - o

Josh Levitsky, MS, MD

Kidney Transplant Surgeon , Northwestern University 

"TruGraf is a predictive model predicting reversible subclinical rejection. TruGraf is meant to guide clinicians in their transplant patient’s recovery."

Copy of Copy of Copy of Copy of Copy of Register and visit us at our ASTS CEoT virtual booth

Wendy Freeman

TruGraf patient 

"TruGraf is a real kidney protector! Now I feel in control of my own health. I don’t have to have all these regular scheduled biopsies."

This is not an official function of the CEoT Meeting and is not endorsed by AST

Join our Community I #TruGraf #TransplantGenomics #TruStory